Literature DB >> 28351300

Roles of zinc-fingers and homeoboxes 1 during the proliferation, migration, and invasion of glioblastoma cells.

Ryuk-Jun Kwon1,2, Myoung-Eun Han1,2, Youn-Jae Kim3, Yun Hak Kim1,2, Ji-Young Kim1,2, Liangwen Liu1,2, Woong Heo4, Sae-Ock Oh1,2.   

Abstract

Zinc-fingers and homeoboxes 1 (ZHX1) is a nuclear transcription repressor and known to be involved in cell differentiation and tumorigenesis. However, the pathophysiological roles of ZHX1 have not been characterized in glioblastoma. We examined ZHX1 expression in glioblastoma patients' tissues and analyzed overall survival of the patients based on expression level of ZHX1. We also examined the effects of ZHX1 on proliferation and motility of glioblastoma cells. In silico analysis and immunohistochemical studies showed that the messenger RNA and protein expressions of ZHX1 were higher in the tissues of glioblastoma patients than in normal brain tissues, and that its overexpression was associated with reduced survival. In vitro, the downregulation of ZHX1 decreased the proliferation, migration, and invasion of glioblastoma cells, whereas its upregulation had the opposite effects. In addition, we showed ZHX1 could contribute to glioblastoma progression via the regulations of TWIST1 and SNAI2. Taken together, this study demonstrates that ZHX1 plays crucial roles in the progression of glioblastoma, and its findings suggest that ZHX1 be viewed as a potential prognostic maker and therapeutic target of glioblastoma.

Entities:  

Keywords:  Glioblastoma; invasion; migration; proliferation; zinc-fingers and homeoboxes 1

Mesh:

Substances:

Year:  2017        PMID: 28351300     DOI: 10.1177/1010428317694575

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  7 in total

1.  Transcription factor SNAI2 exerts pro-tumorigenic effects on glioma stem cells via PHLPP2-mediated Akt pathway.

Authors:  Lilei Peng; Jie Fu; Yitian Chen; Yang Ming; Haiping He; Shan Zeng; Chuanhong Zhong; Ligang Chen
Journal:  Cell Death Dis       Date:  2022-06-02       Impact factor: 9.685

2.  Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy.

Authors:  Yanjie You; Fangrui Hu; Shengjuan Hu
Journal:  Oncol Lett       Date:  2022-05-25       Impact factor: 3.111

3.  Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients.

Authors:  Yanjie You; Yuhong Ma; Qiang Wang; Zhengcai Ye; Yanhong Deng; Feihu Bai
Journal:  Cancer Manag Res       Date:  2019-02-05       Impact factor: 3.989

4.  Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression.

Authors:  Keman Liao; Yingying Lin; Weizhen Gao; Zhipeng Xiao; Rogelio Medina; Pauline Dmitriev; Jing Cui; Zhengping Zhuang; Xiaochun Zhao; Yongming Qiu; Xiaohua Zhang; Jianwei Ge; Liemei Guo
Journal:  Mol Ther Nucleic Acids       Date:  2019-09-17       Impact factor: 8.886

5.  ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.

Authors:  Minhua Deng; Wensu Wei; Jinling Duan; Rixin Chen; Ning Wang; Leye He; Yulu Peng; Xiaodan Ma; Zeshen Wu; Jianye Liu; Zhiyong Li; Zhiling Zhang; Lijuan Jiang; Fangjian Zhou; Dan Xie
Journal:  Cancer Sci       Date:  2021-03-09       Impact factor: 6.716

Review 6.  Zinc Fingers and Homeobox Family in Cancer: A Double-Edged Sword.

Authors:  Yonghua Bao; Haifeng Zhang; Zhixue Han; Yongchen Guo; Wancai Yang
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

Review 7.  Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.

Authors:  Sara Momtazmanesh; Nima Rezaei
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.